FIELD: medicine.
SUBSTANCE: individual's peripheral blood is examined to measure the absolute content of natural killers (CD16+ lymphocytes) and the concentration of soluble apoptosis receptor (sAPO-1). If the CD16+ content is more than 0.5×109 cell/l, whereas the sAPO-1 concentration is more than 4,000 pg/ml, the risk of malignant new growths is predicted.
EFFECT: using the given method enables detecting the malignant new growth at the early stages with using immunological methods.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTION OF RISK OF DEVELOPING NEW GROWTHS OF ORAL MUCOSA IN PATIENTS AGED OVER 40 YEARS | 2015 |
|
RU2611343C1 |
| PREDICT THE RISK OF MALIGNANCY OF THE NODAL FORMATIONS IN PATIENTS WITH ENDOCRINOLOGICAL DISEASES | 2017 |
|
RU2657417C1 |
| METHOD OF PREDICTING DISSEMINATION OF TUMOUR PROCESS IN PATIENTS WITH STOMACH CANCER | 2011 |
|
RU2455924C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS | 2009 |
|
RU2426991C2 |
| METHOD FOR PREDICTING EFFICACY OF CYTOSTATIC CHEMOTHERAPY IN PATIENTS SUFFERING MALIGNANT NEW GROWTHS OF EPITHELIAL TISSUES | 2014 |
|
RU2546533C9 |
| METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN BREAST CANCER PATIENTS AFTER ANTICANCER TREATMENT | 2010 |
|
RU2436099C1 |
| METHOD FOR ASSESSING RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS WITH CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS | 2014 |
|
RU2574896C2 |
| METHOD OF PREDICTING EFFECTOR FAILURE OF CYTOTOXIC CELLS BY INCREASING CONCENTRATIONS OF SCD54, SCD56, SCD71 MOLECULES IN THE BLOOD | 2023 |
|
RU2811001C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CHRONIC CARDIAC INSUFFICIENCY IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2599501C1 |
| METHOD OF TREATING PAPILLOMA VIRAL INFECTIONS IMPLEMENTED THROUGH INTERLEUKIN-18 INDUCTION | 2010 |
|
RU2482866C2 |
